Abstract
The accurate diagnosis of bladder cancer along with the proper evaluation of prognostic and predictive factors is critical for pathology practice in bladder diseases and allows for appropriate disease management and increased rates of patient survival. With its high prevalence and an aging population, pathologists will face more bladder cancer cases in the coming years. Differentiating between benign mimickers and other types of malignancy is central to the practice of pathology. Incorporating molecular advances in pathology is the future trend for the practice. This book summarizes pathologic findings with important prognostic factors, including the staging and grading of bladder cancers and the most recent advances in bladder molecular pathology, and serves a tool for practicing pathologists, clinicians, and trainees.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Richters A, Aben KKH, Kiemeney L. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895–1904
Global cancer observatory: cancer today. International agency for research on cancer. Available from: https://gco.iarc.fr/today. Cited 01 May 2020.
Cancer Facts and Statistics. American cancer society Atlanta, GA: American cancer society; 2020.
Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013;64(4):639–53.
Moch H. HPA, Ulbright T.M., Reuter V.E. WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed. Lyon, France: IARC Press; 2016.
World Population Prospects 2019: Highlights (ST/ESA/SER.A/423). . United Nations, Department of Economic and Social Affairs, Population Division 2019.
World Population Ageing 2017 - Highlights (ST/ESA/SER.A/397). United Nations, Department of Economic and Social Affairs, Population Division 2017.
Vakar-Lopez F, Shen SS, Zhang S, Tamboli P, Ayala AG, Ro JY. Muscularis mucosae of the urinary bladder revisited with emphasis on its hyperplastic patterns: a study of a large series of cystectomy specimens. Ann Diagn Pathol. 2007;11(6):395–401.
Paner GP, Ro JY, Wojcik EM, Venkataraman G, Datta MW, Amin MB. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2007;31(9):1420–9.
Lobo N, Shariat SF, Guo CC, Fernandez MI, Kassouf W, Choudhury A, et al. What Is the Significance of Variant Histology in Urothelial Carcinoma? Eur Urol Focus. 2020;6(4):653–663.
Kamat AM, Dinney CP, Gee JR, Grossman HB, Siefker-Radtke AO, Tamboli P, et al. Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients. Cancer. 2007;110(1):62–7.
Sui W, Matulay JT, Onyeji IC, Theofanides MC, James MB, RoyChoudhury A, et al. Contemporary treatment patterns and outcomes of sarcomatoid bladder cancer. World J Urol. 2017;35(7):1055–61.
Kim DK, Kim JW, Ro JY, Lee HS, Park JY, Ahn HK, et al. Plasmacytoid Variant Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of the Clinicopathological Features and Survival Outcomes. J Urol. 2020;204(2):215–223
Ro JY, Shen SS, Lee HI, Hong EK, Lee YH, Cho NH, et al. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases. Am J Surg Pathol. 2008;32(5):752–7.
Huang L, Kong Q, Liu Z, Wang J, Kang Z, Zhu Y. The Diagnostic Value of MR Imaging in Differentiating T Staging of Bladder Cancer: A Meta-Analysis. Radiology. 2018;286(2):502–11.
Heidenreich A, Albers P, Classen J, Graefen M, Gschwend J, Kotzerke J, et al. Imaging studies in metastatic urogenital cancer patients undergoing systemic therapy: recommendations of a multidisciplinary consensus meeting of the Association of Urological Oncology of the German Cancer Society. Urol Int. 2010;85(1):1–10.
Witjes JA, Bruins HM, Cathomas R, Comperat EM, Cowan NC, Gakis G, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol. 2021;79(1):82–104.
Inamura K. Bladder Cancer: New Insights into Its Molecular Pathology. Cancers (Basel). 2018;10(4).
Bera K, Schalper KA, Rimm DL, Velcheti V, Madabhushi A. Artificial intelligence in digital pathology - new tools for diagnosis and precision oncology. Nat Rev Clin Oncol. 2019;16(11):703–15.
Mukhopadhyay S, Feldman MD, Abels E, Ashfaq R, Beltaifa S, Cacciabeve NG, et al. Whole Slide Imaging Versus Microscopy for Primary Diagnosis in Surgical Pathology: A Multicenter Blinded Randomized Noninferiority Study of 1992 Cases (Pivotal Study). Am J Surg Pathol. 2018;42(1):39–52.
Ehteshami Bejnordi B, Veta M, Johannes van Diest P, van Ginneken B, Karssemeijer N, Litjens G, et al. Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer. Jama. 2017;318(22):2199–210.
Nagpal K, Foote D, Liu Y, Chen PC, Wulczyn E, Tan F, et al. Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer. NPJ Digit Med. 2019;2:48.
Bychkov D, Linder N, Turkki R, Nordling S, Kovanen PE, Verrill C, et al. Deep learning based tissue analysis predicts outcome in colorectal cancer. Sci Rep. 2018;8(1):3395.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zhou, H., Guo, C.C., Ro, J.Y. (2021). Conclusion and Remarks. In: Zhou, H., Guo, C.C., Ro, J.Y. (eds) Urinary Bladder Pathology. Springer, Cham. https://doi.org/10.1007/978-3-030-71509-0_19
Download citation
DOI: https://doi.org/10.1007/978-3-030-71509-0_19
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71508-3
Online ISBN: 978-3-030-71509-0
eBook Packages: MedicineMedicine (R0)